The role of dietary choline in the beneficial effects of lecithin on the secretion of biliary lipids in rats.
Earlier studies showed that dietary soybean lecithin increases biliary lipid secretion, which mainly comes from the contribution of high density lipoprotein (HDL) and hepatic microsomal pools of phosphatidylcholine and cholesterol. In addition, a lecithin diet enhances bile secretion and prevents bile acid-induced cholestasis. This study evaluated the contribution of choline, a component of lecithin, to the observed effect of lecithin on biliary secretory function. Rats were fed either a control diet (CD), a choline diet (ChD) or a lecithin-enriched diet (LD) for 2 weeks. Results showed that like LD, ChD induced an increase in bile flow and bile acid secretion rate when compared with the control diet. However, unlike LD, ChD did not significantly increase biliary phospholipids and cholesterol output. An increase of hydrophilic bile acids (i.e. ursodeoxycholic and muricholic acids) in bile of rats fed choline could explain why the biliary phospholipid and cholesterol secretion was not increased. During taurocholic acid infusion, both experimental diets increased bile flow and the bile acid secretion rate maximum (BASRm). The cholestasis usually observed after the BASRm is reached was inhibited by ChD and LD. Both diets induced a decrease in plasma cholesterol (total and HDL), however, only LD induced statistically significant changes. Analysis of total cholesterol and phospholipid content of microsomes and canalicular membranes indicated no statistically significant difference between control and experimental groups either under basal conditions or after bile acid infusion. Similarly, the phospholipid classes and fatty acid composition of biliary phosphatidylcholine were not altered by feeding ChD and LD. We conclude that choline contributes to the beneficial effect of a lecithin diet on bile secretion. It is postulated that this effect may be attributed to modulation of HDL and an enhancement of the cholesterol and phospholipid pools destined for biliary secretion.
LeBlanc
M J
MJ
Department of Nutrition, Université de Montréal, Que., Canada.
Gavino
V
V
Pérea
A
A
Yousef
I M
IM
Lévy
E
E
Tuchweber
B
B
D000818:Animals; D001646:Bile / Q000187:drug effects* / Q000378:metabolism; D001647:Bile Acids and Salts / Q000032:analysis; D001648:Bile Canaliculi / Q000378:metabolism; D002779:Cholestasis / Q000139:chemically induced / Q000378:metabolism; D002784:Cholesterol / Q000032:analysis / Q000097:blood; D002794:Choline / Q000008:administration & dosage / Q000494:pharmacology*; D004032:Diet; D002149:Energy Intake; D005227:Fatty Acids / Q000032:analysis; D007425:Intracellular Membranes / Q000378:metabolism; D008055:Lipids / Q000032:analysis* / Q000097:blood; D008099:Liver / Q000378:metabolism / Q000648:ultrastructure; D008297:Male; D010713:Phosphatidylcholines / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D010743:Phospholipids / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D013656:Taurocholic Acid
D001647:Bile Acids and Salts; D005227:Fatty Acids; D008055:Lipids; D010713:Phosphatidylcholines; D010743:Phospholipids; D013656:Taurocholic Acid; D002784:Cholesterol; D002794:Choline